Back

No stimulant? No Problem: Analyzing Black Market Sales of Atomoxetine on StreetRx

DeSalve, D.; Roe, S.; Piper, B.

2022-12-20 pharmacology and therapeutics
10.1101/2022.12.19.22283638 medRxiv
Show abstract

ObjectiveThe purpose of this report was to analyze black market diversions of atomoxetine, a non-stimulant medication for ADHD, submitted to StreetRx. MethodData related to black market atomoxetine purchases entered on StreetRx between 2015 and 2019 were analyzed. Data included generic drug name, dosage, purchase price, and date and location in the United States. The mean price per milligram was determined and a heatmap generated. ResultsThe average price per milligram cost of 113 diverted atomoxetine submissions was $1.35 ({+/-} $2.76 SD) (Median = $0.05, Min = $0.01, Max = $20.00). The states with the most submissions included Michigan (11), Pennsylvania (9), Indiana (8), and Ohio (8). ConclusionFurture qualitative studies should investigate reasons why individuals are motivated to purchase atomoxetine, a non-stimulant medication, on the black market (recreational vs. nootropic vs. other clinical uses).

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.